ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 128571 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 128571; 2) Community: the network communities that were significantly associated with the response to NSC 128571; 3) Molecule: the relationships between components within communities and NSC 128571; 4) MDR: the compounds that were significantly associated with the NSC 128571.

NSC Compound Enrichment Correlation
NSC 316158 Null 0.0244632509325736 0.21286509
NSC 328130 Null 0.0244632509325736 0.36614038
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0244632509325736 0.27196884
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0244632509325736 0.30021544
NSC 363812 Tetraplatin 0.0244632509325736 0.58025209
NSC 380721 Eremantholide B 0.0244632509325736 0.40613064
NSC 38643 Lenamycin 0.0244632509325736 0.29728145
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0244632509325736 0.57184131
NSC 630511 1,4-Benzoquinone-2-methoxy-5-dimethylaminomethyl- 6-(10-heptadecenyl)-(Z)-, hydrochloride 0.0244632509325736 0.36797227
NSC 639978 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride 0.0244632509325736 0.38403606
Total:135  Current:86    [First] [Prev] [Next] [Last]